Aaron Jenkins, PhD

Director, Health Economics & Outcomes Research, Rimegepant
Pfizer R&D UK Ltd., Tadworth, Surrey
Surrey, England, United Kingdom

Aaron Jenkins, PhD is a health economics and outcomes researcher with over 15 years of experience in the pharmaceutical industry, specialising in health technology appraisals and real-world evidence. Currently, he is a Value and Evidence Director for the global migraine team at Pfizer.

Disclosure information not submitted.

Presentation(s):

• P-072 - A retrospective cohort study comparing persistence between rimegepant and oral triptans for the acute treatment of migraine in the United States.

  POSTER ABSTRACT